If telehealth can consistency provide a convenient virtual environment, as well as a clinical workflow that identifies which patients and conditions are appropriate for telehealth services, it’s far more likely to be able to compete with in-person care, according to Joseph Kvedar, MD, Senior Advisor, at the MGH Center for Innovation.
“We’re Putting Lives at Risk”: What the Proposed DEA Rules Mean for Behavioral Health
With the public health emergency scheduled to expire, the DEA has proposed rules that put patients at risk of “not getting critical, clinically appropriate medications, which in turn puts their lives at risk,” said Dr. Joseph Kvedar. In this blog, he provides information on how leaders can get involved and help prevent a “potential public health crisis.”
“A Reliable Playbook”: What It Takes to Fix Telehealth’s Trust Problem
“Speaking with Confidence”: Dr. Kvedar Examines the Evidence Base for Digital Health
The answer to the most basic question surrounding telehealth — ‘Is it as good as in-person care?’ — is anything but simple, according to Dr. Joseph Kvedar. In this piece, he examines the pros and cons of different types of clinical research and shares examples from recent literature that can help uncover some answers.